Most sold healthcare stocks in Q4 2017

See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2017, measured as net reductions in reported share positions from Q3 2017 into Q4 2017. Notable reductions at the top of this list include IDEXX LABORATORIES INC (IDXX), BAXTER INTERNATIONAL INC (BAX), PFIZER INC (PFE), MCKESSON CORP (MCK). These rankings aggregate SEC 13F filings from all institutional investors in our database.

Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.−15.2M−11.4M−7.6M−3.8M0.00Net change in reported shares (all institutional filers)IDXXBAXPFEMCKMRKEWJNJWBATDOCABBVPDCOHALOAMRNOPKALNYPINCEXELCTLTOSURAZTASymbol
SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
IDXXIDEXX LABORATORIES INC-13,798,458-$848.64M01203
BAXBAXTER INTERNATIONAL INC-5,385,767-$261.48M01408
PFEPFIZER INC-5,071,884-$170.92M148015
MCKMCKESSON CORP-3,650,915-$542.72M14227
MRKMERCK & CO. INC.-2,499,504-$329.82M192114
EWEDWARDS LIFESCIENCES CORP-2,110,280-$214.09M11214
JNJJOHNSON & JOHNSON-1,646,066$8.15M1212019
WBAWALGREENS BOOTS ALLIANCE INC-1,633,799-$143.13M11437
TDOCTELADOC HEALTH INC-1,535,967-$50.46M01102
ABBVABBVIE INC-1,436,248-$122.97M026110
PDCOPATTERSON COS INC-1,426,918-$80.39M00313
HALOHALOZYME THERAPEUTICS INC-1,168,657-$4.47M11104
AMRNAMARIN CORP PLC -ADR-1,106,614-$2.73M00101
OPKOPKO HEALTH INC-917,500-$6.61M00101
ALNYALNYLAM PHARMACEUTICALS INC-908,776-$27.98M10203
PINCPREMIER INC-CLASS A-742,189-$27.39M01203
EXELEXELIXIS INC-716,700$1.65M00101
CTLTCATALENT INC-686,900-$25.68M00102
OSURORASURE TECHNOLOGIES INC-679,603-$29.86M00101
AZTAAZENTA INC-571,257-$17.41M00101
GRFSGRIFOLS SA-ADR-571,242-$3.00M00202
DHRDANAHER CORP-518,105$106.39M234111
UHSUNIVERSAL HEALTH SERVICES-B-500,932-$53.77M01102
THCTENET HEALTHCARE CORP-498,613-$8.19M00010
SYKSTRYKER CORP-488,760$48.83M01405
CNCCENTENE CORP-432,478-$37.53M10203
HUMHUMANA INC-418,400-$87.54M00101
HQYHEALTHEQUITY INC-324,500-$16.55M00011
UNHUNITEDHEALTH GROUP INC-298,671$667.37M1213017
CRLCHARLES RIVER LABORATORIES-279,757-$26.21M01203
GMEDGLOBUS MEDICAL INC - A-258,100-$2.88M00101
PETSPETMED EXPRESS INC-233,715$12.44M00101
SRNESORRENTO THERAPEUTICS INC-233,563-$245.00K00011
CDXSCODEXIS INC-220,500-$646.00K00101
VREXVAREX IMAGING CORP-211,061$10.25M01304
KURAKURA ONCOLOGY INC-177,106-$2.62M00101
INVAINNOVIVA INC-175,643-$2.28M01102
ADAPADAPTIMMUNE THERAPEUTICS-ADR-161,100-$2.82M00101
MMSIMERIT MEDICAL SYSTEMS INC-137,612-$5.83M00010
PBYIPUMA BIOTECHNOLOGY INC-134,600-$16.12M00010
MASIMASIMO CORP-131,300-$12.34M00101
SNYSANOFI-ADR-130,342-$457.97M00406
USPHU.S. PHYSICAL THERAPY INC-113,700-$591.00K00101
RGENREPLIGEN CORP-112,300-$4.40M00101
ICUIICU MEDICAL INC-110,300-$10.47M00101
VCELVERICEL CORP-104,792-$709.00K00101
RDYDR. REDDY'S LABORATORIES-ADR-101,800-$3.45M00011
LMATLEMAITRE VASCULAR INC-95,600-$4.45M00101
BLUEBLUEBIRD BIO INC-91,869-$7.67M00111
HCSGHEALTHCARE SERVICES GROUP-81,401-$4.46M10102

Frequently asked questions about Most sold healthcare stocks in Q4 2017

  • What are the most sold Healthcare stocks in Q4 2017?

    The most sold healthcare stocks in Q4 2017 are those with the largest decrease in reported share counts across institutional investors compared to Q3 2017, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2017?

    Among filers in this sector, net reductions were largest in companies such as IDEXX LABORATORIES INC (IDXX), BAXTER INTERNATIONAL INC (BAX), PFIZER INC (PFE), based on aggregated 13F data.

  • How is institutional selling calculated?

    Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2017).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.